Insider plans sale of 2,476 common shares

An affiliated shareholder has filed notice of an intended sale of 2,476 shares of common stock through Fidelity Brokerage Services LLC on or around February 17, 2026 on the NASDAQ.

Rhea-AI Filing Summary

An affiliated shareholder has filed notice of an intended sale of 2,476 shares of common stock through Fidelity Brokerage Services LLC on or around February 17, 2026 on the NASDAQ. The filing lists an aggregate market value of $1,211,902.96 for these shares, compared with 254,034,190 shares outstanding.

The shares to be sold were acquired on February 13, 2026 through restricted stock vesting from the issuer as compensation. The notice also details prior sales in the last three months by Jonathan P. Biller, including several smaller common‑stock transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the insider trading notice for VRTX disclose?

It discloses an intended sale of 2,476 common shares on NASDAQ with an aggregate market value of $1,211,902.96. The shares were recently acquired through restricted stock vesting as compensation from the issuer.

Who is the selling security holder in the recent VRTX notice?

The notice identifies Jonathan P. Biller as the person whose account the securities are to be sold. It also lists his prior three‑month common‑stock sales, including transactions on December 3, 2025 and February 11 and 13, 2026.

How many VRTX shares are planned for sale and on which exchange?

The filing states that 2,476 common shares are planned for sale with an aggregate market value of $1,211,902.96. The intended transaction is to occur on the NASDAQ through Fidelity Brokerage Services LLC.

How were the VRTX shares being sold acquired by the insider?

The shares were acquired on February 13, 2026 via a restricted stock vesting transaction from the issuer, described as compensation. The same date is listed for both the acquisition and payment, indicating a non‑cash, equity‑based award.

What recent VRTX stock sales has Jonathan P. Biller reported?

He reported three recent common‑stock sales: 347 shares on December 3, 2025 for $155,803.00, 1,925 shares on February 11, 2026 for $886,327.75, and 988 shares on February 13, 2026 for $493,012.00.

How many VRTX shares are outstanding compared with the planned sale?

The document reports 254,034,190 shares outstanding of the issuer’s common stock. The intended transaction covers 2,476 shares, and this outstanding share count serves as a baseline reference for the company’s total equity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 01:52 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001744749
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Biller Jonathan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2476	1211902.96	254034190	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Restricted Stock Vesting	Issuer			2476	02/13/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan P. Biller 50 Northern Avenue Boston MA 02210	Common	12/03/2025	347	155803.00
Jonathan P. Biller 50 Northern Avenue Boston, MA 02210	Common	02/11/2026	1925	886327.75
Jonathan P. Biller 50 Northern Avenue Boston MA 02210	Common	02/13/2026	988	493012.00

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jonathan P. Biller
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)